Rezulin (also called Troglitazone) is a prescription drug which was withdrawn from the market on March 21, 2000 due to numerous reports of death and liver injuries among Rezulin users. While on the market from 1997 until 2000, Rezulin generated over $1.8 billion in sales. Rezulin was used for treating Type 2 diabetics but, it quickly became clear that Rezulin's severe side effects far outweighed its benefits.

Rezulin users' risk of liver failure is increased 1200 times by taking Rezulin. Some Rezulin patients have suffered severe liver damage resulting in death or liver transplant surgery. Liver damage can be extremely difficult to detect early on. In later stages, the symptoms may include yellow eyes, abdominal pain, nausea, clay colored stools and dark urine.

If you believe that Rezulin use may have put you or a loved one in danger, please contact us through this website to obtain a free consultation and learn more.

"YOUR FUTURE DEPENDS ON WHAT YOU DO TODAY"
Don't let them mistreat you or your loved ones.
Just call 1-(800)-827-7898.
We are here to help you and answer your questions.